A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2011
11/29/2011	US8067564 Methods of obtaining a specific binding member that binds eotaxin
11/29/2011	US8067533 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067388 Decoy-containing pharmaceutical compositions and method of using the same
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	US8066976 Foaming compositions for hair care
11/29/2011	US8066975 Psoriasis or seborrheic dermatitis; mixture of clobetasol propionate, an anionic surfactant (sodium lauryl ether sulfate), an amphoteric surfactant ( cocamidopropyl betaines); a propenetrating agent chosen from ethanol, isopropanol, propylene glycol and ethoxydiglycol; foam with good compactnes; shampoo
11/29/2011	DE202011001708U1 Kosmetisches Polymer-Gel mit heilender Wirkung Cosmetic polymer gel with healing properties
11/29/2011	CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011	CA2638985C Therapeutic agent containing .omega.-feline interferon for treating feline atopic dermatitis
11/29/2011	CA2579032C Use of an .delta.-amino acid as thymocyte growth agent
11/29/2011	CA2486910C Ophthalmological use of roflumilast for the treatment of diseases of the eye
11/29/2011	CA2473634C 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
11/29/2011	CA2453843C Substituted 4-aminocyclohexanol derivatives
11/29/2011	CA2401241C 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
11/24/2011	WO2011145765A1 Skin preparation composition for external use with excellent antibacterial and antifungal effects
11/24/2011	WO2011145737A1 Composition for improving condition of skin
11/24/2011	WO2011094430A3 Pro-angiogenic fragments of prominin-1 and uses thereof
11/24/2011	WO2011056056A3 Anti-cytokine vhnar domains
11/24/2011	WO2010134047A3 Liquid dosage forms of isotretinoin
11/24/2011	WO2010107482A4 Germicidal composition
11/24/2011	US20110289608 Antisense modulation of interleukins 17 and 23 signaling
11/24/2011	US20110288462 Haemostatic wound care article
11/24/2011	US20110288363 Biologically Enhanced Irrigants
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011	US20110288172 Dermatological compositions and methods
11/24/2011	US20110288165 Novel lipid composition for the treatment of skin problems in companion animals
11/24/2011	US20110288161 Methods for treatment of thiol-containing compound deficient conditions
11/24/2011	US20110288158 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288140 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers
11/24/2011	US20110288116 Iap inhibitors
11/24/2011	US20110288107 Topical formulation for a jak inhibitor
11/24/2011	US20110288097 Pyrrolopyrazine Kinase Inhibitors
11/24/2011	US20110288096 Methods and compositions for treating or preventing erythema
11/24/2011	US20110288092 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
11/24/2011	US20110288088 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
11/24/2011	US20110288077 Compounds for the treatment of inflammatory diseases
11/24/2011	US20110288068 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/24/2011	US20110288067 Pyrrolopyrazine Kinase Inhibitors
11/24/2011	US20110288066 Phenoxy acetic acid derivatives
11/24/2011	US20110288058 Methods for Preventing or Reducing Colon Carcinogenesis
11/24/2011	US20110288056 Once daily formulations of tetracyclines
11/24/2011	US20110288037 Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System
11/24/2011	US20110288031 Identification of a novel bhd gene
11/24/2011	US20110288025 Biopolymer produced by fermenting the extract of soybean with folic acid and a composition containing thereof
11/24/2011	US20110288010 Utilization of peptides as active ingredients for slimming
11/24/2011	US20110288004 Viral Sequences and Uses Thereof
11/24/2011	US20110287113 Treatment of psoriasis
11/24/2011	US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds
11/24/2011	US20110287103 Sustained-release formulations of topiramate
11/24/2011	US20110287088 Modulation of olfml-3 mediated angiogenesis
11/24/2011	US20110287083 Bioabsorbable Composition and Coatings Including Same
11/24/2011	US20110287082 Multilayer Scaffold
11/24/2011	US20110287079 Supporting material for cell sheet
11/24/2011	US20110287074 Antimicrobial Compositions, Methods of Manufacture Thereof and Articles Comprising the Same
11/24/2011	US20110287068 Fibrin and fibrinogen matrices and uses of same
11/24/2011	US20110287063 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/24/2011	US20110287061 Dietary composition and method for promoting healthy hair growth and melanogenesis
11/24/2011	US20110287049 Prevention and treatment of amyloidogenic diseases
11/24/2011	US20110287048 Antigen Specific Tregs and related compositions, methods and systems
11/24/2011	US20110287040 Materials and methods for treatment of inflammation
11/24/2011	US20110287032 Novel ctla4-ig immunoadhesins
11/24/2011	US20110287030 Compositions and methods for diagnosing and treating an inflammation
11/24/2011	US20110287028 Methods of Treatment Using Human Anti-IL-23 Antibodies
11/24/2011	US20110287022 Interferon alpha-induced pharmacodynamic markers
11/24/2011	US20110287017 Anti-p-selectin antibodies and methods of their use and identification
11/24/2011	US20110286991 Peptides derived from hmg-coa reductase and cosmetic and/or pharmaceutical composition containing same
11/24/2011	US20110286985 Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous hif-1a
11/24/2011	US20110286963 Human soluble cd146, preparation and uses thereof
11/24/2011	US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use
11/24/2011	US20110286944 Methods and compositions for safe and effective treatment of erythema
11/24/2011	CA2799393A1 Skin preparation composition for external use with excellent antibacterial and antifungal effects
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP2388009A1 Dermatological composition containing avermictin nanocapsules, method for preparing the same and uses thereof
11/23/2011	EP2388007A1 Compounds, formulations, and methods for treating or preventing rosacea
11/23/2011	EP2387990A1 Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies
11/23/2011	EP2387573A1 6-phenyl-lh-imidazo ý4, 5-c¨pyridine-4-carbonitrile derivatives as cathepsin s and/or cathepsin k inhibitors
11/23/2011	EP2387442A1 Carrier in oil-in-water emulsion form, particularly for cosmetic or dermatological use
11/23/2011	EP2387396A1 Agent for preventing and treating pityriasis versicolor
11/23/2011	EP2004576B1 New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use
11/23/2011	EP1735277B1 2-alkylidene-18,19-dinor-vitamin d compounds
11/23/2011	EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
11/23/2011	EP1435787B1 Nestin-expressing hair follicle stem cells
11/23/2011	EP1385527B2 Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof
11/23/2011	EP1362105B1 Anti-interferon-alpha antibodies
11/23/2011	EP1349576B1 Combined use of enzyme inhibitors for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with follicular and epidermal hyperkeratosis and reinforced keratinocyte proliferation
11/23/2011	CN202043972U Health-care pillow with headrest provided with three layers of medicine cushions
11/23/2011	CN1691947B Application of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
11/23/2011	CN1671351B NSAID-containing topical formulations that demonstrate chemopreventive activity
11/23/2011	CN102256930A Polyunsaturated fatty acid and diol ester as an anti-acne agent
11/23/2011	CN102256666A A composition and method of treating skin conditions
11/23/2011	CN102256591A Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
11/23/2011	CN102250736A Health-care medicated wine and preparation method thereof
11/23/2011	CN102250734A Linearstripe rabdosia herb combined propolis wine and preparation method thereof
11/23/2011	CN102250733A Health-care wine matched with gynostemma pentaphylla and preparation method thereof
11/23/2011	CN102250732A Tussah female moth beautifying wine for women, and production process thereof
11/23/2011	CN102250253A Fusogenic peptide containing thrombin fragment
11/23/2011	CN102250217A Hyla simplex skin injury repair promotion polypeptides and genes as well as application thereof
11/23/2011	CN102250179A Stable protein kinase activator, and preparation method and purpose thereof

1 ... 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... 1065